Maternal Choline Supplementation Influences Placental Glucose Uptake and Metabolism in a Manner Dependent on Fetal Sex
Sze Ting (Cecilia) Kwan,Julia H. King,Jian Yan,Xinyin Jiang,Jason S. Hutzler,Mark S. Roberson,Marie A. Caudill
DOI: https://doi.org/10.1096/fasebj.30.1_supplement.272.5
2016-01-01
The FASEB Journal
Abstract:The placenta is responsible for delivering nutrients such as glucose to the fetus to support its growth and development, which is especially important during late gestation when fetal growth is most rapid. The ability of the placenta to efficiently provide nutrients is dependent on its vascular development and the abundance of nutrient transporters at the maternal fetal interface. Maternal choline supplementation (MCS) was shown to improve placental vasculature, but it is still unknown if MCS affects placental transporter abundance and fetal nutrient delivery. To test the hypothesis that MCS beneficially modulates placental glucose supply, pregnant mice were fed a diet containing 1, 2 or 4 times the recommended choline level. The placentas were collected at gestational day (E) 15.5 and 18.5 for evaluating the expression of key glucose transporters and enzymes involved in glycogen metabolism as well as the glycogen concentration. Data were analyzed using a mixed linear model. At E15.5, MCS reduced the membrane protein abundance of Glut1 transporter as well as the mRNA expression of the glycogen synthesizing enzyme Gys1 (p<0.05). The mRNA expression of the glycogen catabolic enzyme Pygm in the female placentas also tended to increase (p=0.08). Consistent with these findings, histological staining of placental glycogen tended to be lower (p=0.08). At E18.5, MCS had no effect on Glut1 transporter expression in either male or female placentas. However, MCS increased the membrane protein abundance of Glut3 transporter and the mRNA abundance of Gys1 in the female placentas (p<0.05). These changes resulted in a 2‐fold increase in glycogen concentration in the female placentas, as shown by histological staining and biochemical measurement (p<0.05). No such changes were seen in the male placentas at this time point. Overall, these data indicate that MCS modulates placental glucose transporter expression and glycogen metabolism in a manner highly dependent on fetal sex. We suggest that these choline‐mediated changes in placental glucose metabolism differentially influence glucose delivery to the fetus, with potential consequences on offspring development and disease risk in later life.Support or Funding InformationUSDA and Egg Nutrition Center
What problem does this paper attempt to address?